Navigation Links
Risk Of Colorectal Polyps Recurrence Can Be Controlled By Rofecoxib

e taking placebo (41 percent vs 55 percent; p<0.0001; relative risk 0.76; 95 percent CI 0.69-0.83). Rofecoxib also reduced the risk of advanced adenomas, which are polyps that are more likely to become cancerous (p<0.01). The benefit was larger in the first year (RR 0.65; 95 percent CI 0.57-0.73) than in the subsequent two years (RR = 0.81, 95 percent CI 0.71-0.93). In the year following three years’ treatment, patients taking rofecoxib experienced a slightly increased risk of any adenoma, but not of advanced adenomas. However, over the entire length of the trial (three years of treatment and one year off drug), patients taking rofecoxib experienced a reduction of the risk of any adenoma.

About the Study
The study included 2,587 evaluable patients with a recent history of confirmed colorectal polyps followed at 108 sites in the United States and abroad. After removal of all polyps, patients were randomized to receive either placebo or 25 mg rofecoxib (the average daily recommended dose) on a daily basis. The primary endpoint was all polyps diagnosed during the three-year treatment period based upon colonoscopies conducted one year and three years after baseline. In addition, an extension to the APPROVe study was conducted to assess recurrence of adenomas in the year following the end of the three years’ treatment through colonoscopy at year four.

Patients treated with rofecoxib experienced more serious adverse events, including significant upper gastrointestinal events and, as reported previously, increased risks of thrombotic cardiovascular events (Bresalier et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. NEJM 2005;352:1092-102). Dr. Baron does not believe that the side effects will derail the eventual development of effective chemoprevention.

'While the toxicity of the currently available COX-2 inhibitors may be problematic, the demonstration of efficacy certainly imp
'"/>




Page: 1 2 3 4 5

Related medicine news :

1. Detecting Colorectal Cancer
2. Preventing Colorectal Cancer
3. Screening Test For Early Diagnosis Of Colorectal Cancer
4. Milk Found To Lower Colorectal-Cancer Risk By 12 %
5. New Treatment Option for Colorectal Cancer
6. Alcohol Consumption A Threat To Colorectal Tumours
7. Alcohol Drinking Affects Risk Of Colorectal Tumours
8. Women More Prone To Risk of Colorectal Cancer from Tobacco
9. Meta Analysis Links Diabetes And Colorectal Cancer
10. Colorectal Cancer Can Be Detected By a Simple Test
11. Smoking and Drinking Could Lead Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Risk Colorectal Polyps Recurrence Can Controlled Rofecoxib

(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... healthcare services programs, the organization has hired two new ... Ph.D. They will report to Grace Pavlath, Ph.D, ... President and Scientific Program Director, and together will lead ... to treatments and cures for various types of neuromuscular ...
(Date:3/6/2015)... 2015 “On Tap” takes the audience on ... stage, to the silver screen and to modern day rhythm ... numbers and their famous eye-high kicks! Producers, directors and choreographers ... of tap dancing in this robust show, showcasing one of ... United States. , “On Tap” is proud to host ...
(Date:3/6/2015)... US Sports Football Camps expands its ... two non-contact specialty camps and one contact football camp. ... Training, located at Bowie State University and Riverdale Baptist ... skills, speed and strength of football athletes. The contact ... Marvin Graves, former quarterback in the Canadian Football League, ...
(Date:3/6/2015)... March 06, 2015 At Natural ... announced today the launch of its powerful, location-aware ... healthy and sustainable products at any retailer that ... exhibiting at Expo West Booth 6054. , ... gluten-free, Kosher, non-GMO, organic, Paleo, and vegan, among ...
(Date:3/6/2015)... Bakersfield, California (PRWEB) March 06, 2015 ... $5.7 million jury verdict on March 5, 2015 in ... County. According to court documents, a jury of 12 ... she suffered from being implanted with an Ethicon TVT ... of nine men and three women also awarded $5 ...
Breaking Medicine News(10 mins):Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3
... in the United Kingdom, a 47-year-old gay man, Mark James was ... ,Judge Jonathan Lowen, who gave the verdict, expressed that ... risks. James had been aware of his HIV status for seven ... his partner in the dark. The partner got wind of the ...
... across New Zealand have significantly reduced the number of people ... Brian Smith said that the poker machine revenue fell 28%. ... a year from pub charities to various sports and other ... found that calls received by the gambling helpline also reduced ...
... Medical Center has been named a Bariatric Surgery Center ... (ASBS).// ,This new designation recognizes the ... bariatric surgical team at Mount Sinai. The hospital has ... ASBS to be acknowledged for its excellence in bariatric ...
... fewer reactions but get the same protection (immunogenicity) as ... today. ,In the UK, primary care practitioners ... of age. Despite recommendations for use of a wide-long ... a narrow-short (25G, 16mm) needle and uncertainty has arisen ...
... of a zoo animal, an Australian black swan, in Germany ... among animal-lovers.// ,So far bird flu had only ... death of the Australian black swan at Dresden Zoo in ... a century or more to might be decimated by the ...
... Officials in the NHS have confirmed that around 1,200 jobs ... to the streamlining process following the merger// of two hospitals. ... which are subject to official consultations with staff, would be ... the cutbacks due to the merger of the Nottingham City ...
Cached Medicine News:Health News:Medical Center Recognized for Excellence in Bariatric Surgery 2Health News:Longer Needles Best for Infant Immunisation 2Health News:Hundreds Of Jobs To Be Lost With The Merger Of Two Major Hospitals In UK 2
(Date:3/6/2015)... Del. , March 6, 2015 ... and Trademark Office,s publication of U.S. Patent Application ... Disorder."  The ,249 Patent Application features claimed methods of ... be used to treat Binge Eating Disorder (,BED,)," ... material," or "flyer or an advertisement," as well ...
(Date:3/5/2015)... 2015 BioLineRx (NASDAQ: BLRX ... to identifying, in-licensing and developing promising therapeutic candidates, ... public offering of American Depositary Shares ("ADSs"), each ... of the ADSs in the offering are to ... Securities is acting as sole book-running manager for ...
(Date:3/5/2015)... Calif., March 5, 2015  IRIDEX Corporation (Nasdaq: ... and year ended January 3, 2015.  , Revenues ... record for the Company and up 11% from $10.6 million ... million, also a record, up 12% from $38.3 million in ... was 50.1%, up from 48.6% in the fourth quarter of ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8
... 2011 A letter sent by a commercial insurer ... drug use when combining anti-clotting drug clopidogrel (Plavix®) with ... in the number of members combining the drugs, according ... leader Prime Therapeutics (Prime). Details of the study will ...
... PHOENIX, April 18, 2011 Altitude Organic Corporation ... company, announced today that it has launched its ... Scottsdale headquarters.  Visit the DoctorMMJ.com website ( www.DoctorMMJ.com ... professional, and entirely legal medical marijuana evaluation in ...
Cached Medicine Technology:Study Finds Letter to Health Care Providers Results in Reduction of Potentially Unsafe Concurrent Use of Plavix and Proton Pump Inhibitors 2Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 2Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 3
... The only dedicated, plastic, single use, disposable ... breast needle localization sites, after the needle ... and protruding localization needle from accidental movement ... department to surgery. ,Increase patient confidence in ...
... efficiency for high volume laboratories, the AU2700 ... away time. This high-speed analyzer delivers true ... photometric test results per hour (up to ... 51 tests on-board. Consolidate with Olympus 122 ...
... EPO ELISA is intended for the quantitative determination ... is intended for in vitro diagnostic use, as ... polycythemias. With the advent of the administration of ... red blood cell mass, an erythropoietin assay may ...
... innovative PoleStar N20, exclusively distributed by ... MRI. Combining intra-operative imaging with ... system, PoleStar N20 is one of ... today. , , Exceptional image quality ...
Medicine Products: